Archive: October 2020
HCC
Update on the Diagnosis and Treatment of Hepatocellular Carcinoma
Abstract: Hepatocellular carcinoma (HCC) is the fourth-leading cause of cancer-related mortality worldwide and the fastest-rising cause of cancer-related death in the United States. Given the […]
Endoscopy
COVID-19 and Endoscopy
Sachin Srinivasan, MD, Suneha Sundaram, MD, and Prateek Sharma, MD
Abstract: The coronavirus disease 2019 (COVID-19) pandemic has caused significant disruptions in health care. Gastrointestinal (GI) societies have strongly recommended the rescheduling of elective procedures […]
HCC
Risk of Hepatocellular Carcinoma Using Tenofovir Disoproxil Fumarate Vs Entecavir for Hepatitis B Virus Treatment
Robert Wong, MD, MS
G&H What is the current understanding of the relationship between hepatocellular carcinoma and hepatitis B virus infection? RW Patients infected with chronic hepatitis B virus […]
IBD
Management of Inflammatory Bowel Disease With Telemedicine
Corey A. Siegel, MD, MS
G&H What are some of the forms of telemedicine that have been used in the management of inflammatory bowel disease? CS There are many different […]
Hepatitis C
Six-Week Therapy for Hepatitis C Virus
David Bernstein, MD
G&H How has the duration of hepatitis C virus treatment evolved over time? DB Hepatitis C virus (HCV) treatment has seen a tremendous evolution, from interferon, […]
Gastro-Hep News
Gastro-Hep News
Samantha Alleman
Guidelines Released for the Diagnosis and Treatment of Achalasia The American College of Gastroenterology released guidelines on the diagnosis and treatment of achalasia, including recommendations, key […]
Letter From the Editor
Letter From the Editor: Using Telemedicine to Treat Inflammatory Bowel Disease Patients
Gary R. Lichtenstein, MD, AGAF, FACP, FACG
Have you used telemedicine recently to help manage inflammatory bowel disease (IBD) patients? This month’s issue of Gastroenterology & Hepatology includes an interesting interview with […]